<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03920696</url>
  </required_header>
  <id_info>
    <org_study_id>APHP180538</org_study_id>
    <nct_id>NCT03920696</nct_id>
  </id_info>
  <brief_title>Pityriasis Lichenoides : Anatomo-clinical Aspects and Follow-up</brief_title>
  <acronym>EtudePL</acronym>
  <official_title>Pityriasis Lichenoides: Anatomo-clinical Aspects and Follow-up Monocentric Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: Pityriasis lichenoides (PL) is an inflammatory dermatitis of undetermined
      origin consisting of specific papular lesions reflecting an &quot;indolent&quot; lymphoproliferative
      state.

      The current classification is confusing because it mixes semiological and chronological
      notions.

      The objectives of this study are to better describe the clinical, epidemiological,
      histological, phenotypic and evolutionary aspects of PL in an adult population.

      Methods: Investigators will perform a retrospective cohort study including patients with
      clinical and histological diagnosis of PL from the coding of the Department of Pathology of
      Henri-Mondor Hospital and from medical records and photographs of lesions if available,
      between January 2012 and August 2018. A follow-up telephone interviews will also be proposed
      to each patient to collect evolution data. Photographs will be systematically reviewed as
      well as cutaneous samples and a genomic analysis will be performed.

      Conclusion: Investigators would like to better understand clinical, histological features and
      evolutionary aspects of PL in an adult population.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To study clinical Aspects of Pityriasis Lichenoides on a large series of adult patients</measure>
    <time_frame>It will be measured within 6 months of enrollment</time_frame>
    <description>Epidemiological and and clinical aspect description of the lesions from medical charts and photographs: age, sex, suspected trigger of the disease, past medical history, frequency of necrotic lesions, topography of lesions, fever, altered general conditions, treatment modalities of the flare.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To study histological features of Pityriasis Lichenoides</measure>
    <time_frame>It will be measured within 6 months of enrollment</time_frame>
    <description>The histological description will make use of a centralized re-reading of the slides according to a standardized grid (appearance of the epidermis, type and topography of the dermal infiltrate, results of the immunolabelings etc ...). The investigators aim to investigate the frequency of patients with patterns of pityriasis lichenoides mimicking lymphomatoid papulosis or mycosis fungoides and to correlate the histological aspect with clinical lesions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To study molecular features of Pityriasis Lichenoides</measure>
    <time_frame>It will be measured within 6 months of enrollment</time_frame>
    <description>number of clone T in the skin and in the blood.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To study the treatment during patients' monitoring</measure>
    <time_frame>It will be measured within 6 months of enrollment</time_frame>
    <description>number of patients with need of a prolonged treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To study the duration of outbreak during patients' monitoring</measure>
    <time_frame>It will be measured within 6 months of enrollment</time_frame>
    <description>the time to healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To study the relapse during patients' monitoring</measure>
    <time_frame>It will be measured within 6 months of enrollment</time_frame>
    <description>the number of relapses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To study the number of outbreaks during patients' monitoring</measure>
    <time_frame>It will be measured within 6 months of enrollment</time_frame>
    <description>the number of outbreaks</description>
  </secondary_outcome>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Pityriasis Lichenoides</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with Pityriasis Lichenoides
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Patients with Pityriasis Lichenoides selected from histological coding OT0431, seen at
             Henri Mondor and with a diagnosis verified from medical records.

        Exclusion Criteria:

          -  Histological coding error

          -  Histological records of patients in care outside Henri Mondor (cases referred for
             histological expertise only but not seen clinically)

          -  Clinical lesions incompatible with Pityriasis Lichenoides according to classically
             published semiological data

          -  Missing or insufficient medical records for data exploitation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saskia ORO, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique Hôpitaux de Paris - CHU Henri Mondor - Créteil</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Saskia ORO, Doctor</last_name>
    <phone>+33 1 49 81 25 36</phone>
    <email>saskia.oro@aphp.fr</email>
  </overall_contact>
  <reference>
    <citation>Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006 Oct;55(4):557-72; quiz 573-6. Review.</citation>
    <PMID>17010734</PMID>
  </reference>
  <reference>
    <citation>Zang JB, Coates SJ, Huang J, Vonderheid EC, Cohen BA. Pityriasis lichenoides: Long-term follow-up study. Pediatr Dermatol. 2018 Mar;35(2):213-219. doi: 10.1111/pde.13396. Epub 2018 Jan 9.</citation>
    <PMID>29315771</PMID>
  </reference>
  <reference>
    <citation>Lalevee S, Ortonne N, Hotz C, Schlemmer F, Beldi-Ferchiou A, Delfau-Larue MH, Wolkenstein P, Chosidow O, Ingen-Housz-Oro S. Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challenge. Eur J Dermatol. 2018 Dec 1;28(6):834-835. doi: 10.1684/ejd.2018.3410.</citation>
    <PMID>30325315</PMID>
  </reference>
  <reference>
    <citation>Geller L, Antonov NK, Lauren CT, Morel KD, Garzon MC. Pityriasis Lichenoides in Childhood: Review of Clinical Presentation and Treatment Options. Pediatr Dermatol. 2015 Sep-Oct;32(5):579-92. doi: 10.1111/pde.12581. Epub 2015 Mar 26. Review.</citation>
    <PMID>25816855</PMID>
  </reference>
  <reference>
    <citation>Nair PS. A clinical and histopathological study of pityriasis lichenoides. Indian J Dermatol Venereol Leprol. 2007 Mar-Apr;73(2):100-2.</citation>
    <PMID>17456915</PMID>
  </reference>
  <reference>
    <citation>Khachemoune A, Blyumin ML. Pityriasis lichenoides: pathophysiology, classification, and treatment. Am J Clin Dermatol. 2007;8(1):29-36. Review.</citation>
    <PMID>17298104</PMID>
  </reference>
  <reference>
    <citation>Zaaroura H, Sahar D, Bick T, Bergman R. Relationship Between Pityriasis Lichenoides and Mycosis Fungoides: A Clinicopathological, Immunohistochemical, and Molecular Study. Am J Dermatopathol. 2018 Jun;40(6):409-415. doi: 10.1097/DAD.0000000000001057.</citation>
    <PMID>29210716</PMID>
  </reference>
  <reference>
    <citation>Sibbald C, Pope E. Systematic review of cases of cutaneous T-cell lymphoma transformation in pityriasis lichenoides and small plaque parapsoriasis. Br J Dermatol. 2016 Oct;175(4):807-9. doi: 10.1111/bjd.14605. Epub 2016 Jun 20. Review.</citation>
    <PMID>27031678</PMID>
  </reference>
  <reference>
    <citation>Vonderheid EC, Kadin ME, Telang GH. Commentary about papular mycosis fungoides, lymphomatoid papulosis and lymphomatoid pityriasis lichenoides: more similarities than differences. J Cutan Pathol. 2016 Apr;43(4):303-12. doi: 10.1111/cup.12653. Epub 2015 Dec 22. Review.</citation>
    <PMID>26566599</PMID>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>March 12, 2019</study_first_submitted>
  <study_first_submitted_qc>April 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2019</study_first_posted>
  <last_update_submitted>April 15, 2019</last_update_submitted>
  <last_update_submitted_qc>April 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pityriasis Lichenoides;</keyword>
  <keyword>cutaneous lymphoma</keyword>
  <keyword>lymphoproliferation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pityriasis</mesh_term>
    <mesh_term>Pityriasis Lichenoides</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

